Investors on the quest for market-beating returns often employ the strategy of stock picking. Making informed choices in stocks can greatly amplify your wealth.
As of close of business last night, Petmed Express, Inc.’s stock clocked out at $4.14, up 2.99% from its previous closing price of $4.02. In other words, the price has increased by $2.99 from its previous closing price. On the day, 0.79 million shares were traded. PETS stock price reached its highest trading level at $4.42 during the session, while it also had its lowest trading level at $4.0.
Ratios:
To gain a deeper understanding of PETS’s stock, we examine its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 1.77 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 50.91. For the most recent quarter (mrq), Quick Ratio is recorded 0.84 and its Current Ratio is at 1.32. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Lake Street on May 25, 2023, initiated with a Buy rating and assigned the stock a target price of $20.
On January 20, 2022, Sidoti Upgraded its rating to Buy which previously was Neutral but kept the price unchanged to $32.
On November 18, 2021, Morgan Stanley started tracking the stock assigning a Underweight rating and target price of $25.Morgan Stanley initiated its Underweight rating on November 18, 2021, with a $25 target price.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Nov 09 ’23 when FULGONI GIAN bought 41,000 shares for $7.34 per share. The transaction valued at 301,124 led to the insider holds 109,510 shares of the business.
Hulett Mathew N bought 13,850 shares of PETS for $100,551 on Nov 03 ’23. The CEO & President now owns 613,850 shares after completing the transaction at $7.26 per share. On Nov 03 ’23, another insider, Chambers Christine, who serves as the CFO of the company, bought 6,888 shares for $7.26 each. As a result, the insider paid 50,007 and bolstered with 19,888 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, PETS now has a Market Capitalization of 87555616 and an Enterprise Value of 36750820. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.32 while its Price-to-Book (P/B) ratio in mrq is 0.88. Its current Enterprise Value per Revenue stands at 0.133 whereas that against EBITDA is 8.491.
Stock Price History:
The Beta on a monthly basis for PETS is 0.73, which has changed by -0.7243675 over the last 52 weeks, in comparison to a change of 0.24191546 over the same period for the S&P500. Over the past 52 weeks, PETS has reached a high of $16.18, while it has fallen to a 52-week low of $3.95. The 50-Day Moving Average of the stock is -12.15%, while the 200-Day Moving Average is calculated to be -49.59%.
Shares Statistics:
It appears that PETS traded 392.00K shares on average per day over the past three months and 411940 shares per day over the past ten days. A total of 21.08M shares are outstanding, with a floating share count of 20.15M. Insiders hold about 4.73% of the company’s shares, while institutions hold 73.46% stake in the company. Shares short for PETS as of 1713139200 were 4556915 with a Short Ratio of 11.62, compared to 1710460800 on 5347129. Therefore, it implies a Short% of Shares Outstanding of 4556915 and a Short% of Float of 26.950002.
Dividends & Splits
With its trailing 12-month dividend rate of 0.9, PETS has a forward annual dividend rate of 0.60. Against a Trailing Annual Dividend Yield of 0.22388059The stock’s 5-year Average Dividend Yield is 6.36.
Earnings Estimates
The current market rating for Petmed Express, Inc. (PETS) reflects the collective analysis of 2.0 analysts closely monitoring its performance.On average, analysts expect EPS of $0.0 for the current quarter, with a high estimate of $0.06 and a low estimate of -$0.07, while EPS last year was -$0.25. The consensus estimate for the next quarter is -$0.01, with high estimates of $0.01 and low estimates of -$0.03.
Analysts are recommending an EPS of between $0.01 and $0.01 for the fiscal current year, implying an average EPS of $0.01. EPS for the following year is -$0.01, with 2.0 analysts recommending between $0.1 and -$0.12.
Revenue Estimates
In the current quarter, 1 analysts expect revenue to total $65M. It ranges from a high estimate of $65M to a low estimate of $65M. As of the current estimate, Petmed Express, Inc.’s year-ago sales were $62.41MFor the next quarter, 1 analysts are estimating revenue of $79.42M. There is a high estimate of $79.42M for the next quarter, whereas the lowest estimate is $79.42M.
A total of 2 analysts have provided revenue estimates for PETS’s current fiscal year. The highest revenue estimate was $286.57M, while the lowest revenue estimate was $279.56M, resulting in an average revenue estimate of $283.07M. In the same quarter a year ago, actual revenue was $256.86MBased on 2 analysts’ estimates, the company’s revenue will be $299.74M in the next fiscal year. The high estimate is $315.73M and the low estimate is $283.75M.
